PROCEPT Biorobotics Corp (PRCT) - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders held on June 10, 2025. The filing details the outcomes of three proposals submitted to security holders regarding board composition, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following proposals were voted upon at the Annual Meeting:
- Proposal 1 (Election of Directors): All nominees were elected to serve until the 2028 annual meeting.
- Elisabeth Little: 31,829,161 votes For; 10,367,858 votes Withheld.
- Thomas M. Prescott: 41,659,436 votes For; 537,583 votes Withheld.
- Larry Wood: 39,753,246 votes For; 2,443,773 votes Withheld.
- Proposal 2 (Ratification of Auditors): The selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ending December 31, 2025, was approved.
- Votes For: 46,102,549
- Votes Withheld: 420,269
- Abstentions: 28,018
- Proposal 3 (Executive Compensation): The non-binding advisory proposal to approve the compensation of named executive officers was approved.
- Votes For: 40,260,405
- Votes Withheld: 1,906,382
- Abstentions: 30,232
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document is limited to the tabulation of votes.
Investor Verification Checklist
- Verify the total number of shares entitled to vote to contextualize the "Votes Withheld" percentages, particularly for Director Elisabeth Little.
- Review the Definitive Proxy Statement (Schedule 14A) filed on April 25, 2025, for detailed biographies of the elected directors and the specific compensation metrics approved in Proposal 3.
- Confirm the tenure of the newly elected directors, which extends until the 2028 annual meeting.